Works matching IS 19466234 AND DT 2022 AND VI 14 AND IP 670

Results: 10
    1

    Immune checkpoint therapy: Forging ahead.

    Published in:
    Science Translational Medicine, 2022, v. 14, n. 670, p. 1, doi. 10.1126/scitranslmed.adf2947
    By:
    • Sharma, Padmanee;
    • Allison, James P.
    Publication type:
    Article
    2

    Interleukin-2–based therapies in cancer.

    Published in:
    Science Translational Medicine, 2022, v. 14, n. 670, p. 1, doi. 10.1126/scitranslmed.abo5409
    By:
    • Raeber, Miro E.;
    • Sahin, Dilara;
    • Boyman, Onur
    Publication type:
    Article
    3
    4

    What's next for cancer vaccines.

    Published in:
    Science Translational Medicine, 2022, v. 14, n. 670, p. 1, doi. 10.1126/scitranslmed.abo4632
    By:
    • Adamik, Juraj;
    • Butterfield, Lisa H.
    Publication type:
    Article
    5
    6
    7

    In vivo gene immunotherapy for cancer.

    Published in:
    Science Translational Medicine, 2022, v. 14, n. 670, p. 1, doi. 10.1126/scitranslmed.abo3603
    By:
    • Mai, David;
    • June, Carl H.;
    • Sheppard, Neil C.
    Publication type:
    Article
    8

    BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion.

    Published in:
    Science Translational Medicine, 2022, v. 14, n. 670, p. 1, doi. 10.1126/scitranslmed.abn7336
    By:
    • Jung, In-Young;
    • Narayan, Vivek;
    • McDonald, Sierra;
    • Rech, Andrew J.;
    • Bartoszek, Robert;
    • Hong, Gwanui;
    • Davis, Megan M.;
    • Xu, Jun;
    • Boesteanu, Alina C.;
    • Barber-Rotenberg, Julie S.;
    • Plesa, Gabriela;
    • Lacey, Simon F.;
    • Jadlowsky, Julie K.;
    • Siegel, Donald L.;
    • Hammill, Dana M.;
    • Cho-Park, Park F.;
    • Berger, Shelley L.;
    • Haas, Naomi B.;
    • Fraietta, Joseph A.
    Publication type:
    Article
    9

    CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models.

    Published in:
    Science Translational Medicine, 2022, v. 14, n. 670, p. 1, doi. 10.1126/scitranslmed.abn1082
    By:
    • Wei, Joyce;
    • Montalvo-Ortiz, Welby;
    • Yu, Lola;
    • Krasco, Amanda;
    • Olson, Kara;
    • Rizvi, Sahar;
    • Fiaschi, Nathalie;
    • Coetzee, Sandra;
    • Wang, Fang;
    • Ullman, Erica;
    • Ahmed, Hassan Shakil;
    • Herlihy, Evan;
    • Lee, Ken;
    • Havel, Lauren;
    • Potocky, Terra;
    • Ebstein, Sarah;
    • Frleta, Davor;
    • Khatri, Aditi;
    • Godin, Stephen;
    • Hamon, Sara
    Publication type:
    Article
    10

    Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies.

    Published in:
    Science Translational Medicine, 2022, v. 14, n. 670, p. 1, doi. 10.1126/scitranslmed.abm1463
    By:
    • Goodman, Daniel B.;
    • Azimi, Camillia S.;
    • Kearns, Kendall;
    • Talbot, Alexis;
    • Garakani, Kiavash;
    • Garcia, Julie;
    • Patel, Nisarg;
    • Hwang, Byungjin;
    • Lee, David;
    • Park, Emily;
    • Vykunta, Vivasvan S.;
    • Shy, Brian R.;
    • Ye, Chun Jimmie;
    • Eyquem, Justin;
    • Marson, Alexander;
    • Bluestone, Jeffrey A.;
    • Roybal, Kole T.
    Publication type:
    Article